PL2173196T3 - Zastosowanie probiotyków i włókien w biegunce - Google Patents
Zastosowanie probiotyków i włókien w biegunceInfo
- Publication number
- PL2173196T3 PL2173196T3 PL08766875T PL08766875T PL2173196T3 PL 2173196 T3 PL2173196 T3 PL 2173196T3 PL 08766875 T PL08766875 T PL 08766875T PL 08766875 T PL08766875 T PL 08766875T PL 2173196 T3 PL2173196 T3 PL 2173196T3
- Authority
- PL
- Poland
- Prior art keywords
- diarrhoea
- probiotics
- fibers
- inulin
- treatment
- Prior art date
Links
- 206010012735 Diarrhoea Diseases 0.000 title abstract 2
- 239000000835 fiber Substances 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
- 229920001202 Inulin Polymers 0.000 abstract 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 1
- 229940029339 inulin Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07111951 | 2007-07-06 | ||
| PCT/NL2008/050454 WO2009008717A1 (en) | 2007-07-06 | 2008-07-04 | Use of probiotics and fibers for diarrhoea |
| EP08766875A EP2173196B1 (en) | 2007-07-06 | 2008-07-04 | Use of probiotics and fibers for diarrhoea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2173196T3 true PL2173196T3 (pl) | 2011-06-30 |
Family
ID=38522548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08766875T PL2173196T3 (pl) | 2007-07-06 | 2008-07-04 | Zastosowanie probiotyków i włókien w biegunce |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20110014167A1 (pl) |
| EP (1) | EP2173196B1 (pl) |
| CN (1) | CN101772308B (pl) |
| AT (1) | ATE498325T1 (pl) |
| DE (1) | DE602008005025D1 (pl) |
| ES (1) | ES2360573T3 (pl) |
| PL (1) | PL2173196T3 (pl) |
| PT (1) | PT2173196E (pl) |
| RU (1) | RU2469558C2 (pl) |
| WO (1) | WO2009008717A1 (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006012536A2 (en) | 2004-07-22 | 2006-02-02 | Ritter Andrew J | Methods and compositions for treating lactose intolerance |
| ES2600960T3 (es) | 2009-02-24 | 2017-02-13 | Ritter Pharmaceuticals, Inc. | Formulaciones prebióticas y procedimientos de uso |
| WO2011137249A1 (en) | 2010-04-28 | 2011-11-03 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| US9987306B2 (en) * | 2012-10-15 | 2018-06-05 | University Of Florida Research Foundation, Inc. | Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract |
| ITMI20131467A1 (it) * | 2013-09-06 | 2015-03-07 | Sofar Spa | Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico |
| WO2015159125A1 (en) * | 2014-04-15 | 2015-10-22 | Compagnie Gervais Danone | Use of lactobacillus rhamnosus for promoting recovery of the intestinal microbiota diversity after antibiotic dysbiosis |
| MA39710A (fr) | 2014-04-23 | 2015-10-29 | Sofar Spa | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin |
| MA45327A (fr) | 2016-05-13 | 2019-03-20 | Sofar Spa | Utilisation de probiotiques pour améliorer l'absorption des protéines |
| MA45288A (fr) | 2016-06-08 | 2019-04-17 | Sofar Spa | Nouvelle utilisation médicale de probiotiques |
| IT201600122724A1 (it) | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
| IT201600127498A1 (it) | 2016-12-16 | 2018-06-16 | Sofar Spa | Probiotici per uso nella diverticolosi e malattia diverticolare |
| RU2767400C2 (ru) * | 2018-07-05 | 2022-03-17 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Пробиотическая композиция для восстановления и поддержания сбалансированной микрофлоры кишечника у детей и младенцев и способ ее получения |
| JP7396798B2 (ja) * | 2019-02-22 | 2023-12-12 | 帝人株式会社 | 腸内酪酸産生促進用組成物 |
| US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
| WO2022269539A1 (en) * | 2021-06-23 | 2022-12-29 | Danstar Ferment Ag | Method for favoring wellness and facilitating self-control before, during and/or after a restrictive diet |
| CN119488548B (zh) * | 2024-09-12 | 2025-08-05 | 东北农业大学 | 一种用于缓解胃肠道腹泻的鼠李糖乳杆菌组合物及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6241983B1 (en) * | 1994-10-28 | 2001-06-05 | Metagenics, Inc. | Bacteria-and fiber-containing composition for human gastrointestinal health |
| EP0904784A1 (en) * | 1997-09-22 | 1999-03-31 | N.V. Nutricia | Probiotic nutritional preparation |
| EP1034787A1 (en) * | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactobacillus strains preventing diarrhea caused by pathogenic bacteria |
| US20040161422A1 (en) * | 1999-04-30 | 2004-08-19 | Natarajan Ranganathan | Nutritional compositions comprising probiotics |
| US20040185032A1 (en) * | 2003-03-18 | 2004-09-23 | David Burrell | Compositions and methods for treating colic |
| EP2033529B1 (en) * | 2003-10-24 | 2019-12-11 | N.V. Nutricia | Synbiotic composition for infants |
| US20090136468A1 (en) * | 2004-10-29 | 2009-05-28 | N.V. Nutricia | Peri-operative composition comprising lactobacillus rhamnosus |
| PT2351492E (pt) * | 2005-02-28 | 2014-12-02 | Nutricia Nv | Composição nutricional com probióticos |
| US20100233312A9 (en) * | 2005-04-11 | 2010-09-16 | The Procter & Gamble Company | Compositions comprising probiotic and sweetener components |
| EP1714660A1 (en) * | 2005-04-21 | 2006-10-25 | N.V. Nutricia | Uronic acid and probiotics |
| US20070218170A1 (en) * | 2006-03-03 | 2007-09-20 | Health Beverage Llc | Fiber Containing Alkaline Beverage and Methods For Production Thereof |
-
2008
- 2008-07-04 RU RU2010104008/13A patent/RU2469558C2/ru not_active IP Right Cessation
- 2008-07-04 WO PCT/NL2008/050454 patent/WO2009008717A1/en not_active Ceased
- 2008-07-04 EP EP08766875A patent/EP2173196B1/en not_active Revoked
- 2008-07-04 ES ES08766875T patent/ES2360573T3/es active Active
- 2008-07-04 DE DE602008005025T patent/DE602008005025D1/de active Active
- 2008-07-04 AT AT08766875T patent/ATE498325T1/de not_active IP Right Cessation
- 2008-07-04 PT PT08766875T patent/PT2173196E/pt unknown
- 2008-07-04 CN CN2008801015524A patent/CN101772308B/zh active Active
- 2008-07-04 PL PL08766875T patent/PL2173196T3/pl unknown
- 2008-07-04 US US12/667,898 patent/US20110014167A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101772308B (zh) | 2013-08-28 |
| US20110014167A1 (en) | 2011-01-20 |
| WO2009008717A1 (en) | 2009-01-15 |
| DE602008005025D1 (de) | 2011-03-31 |
| PT2173196E (pt) | 2011-05-23 |
| EP2173196A1 (en) | 2010-04-14 |
| CN101772308A (zh) | 2010-07-07 |
| RU2010104008A (ru) | 2011-08-20 |
| RU2469558C2 (ru) | 2012-12-20 |
| EP2173196B1 (en) | 2011-02-16 |
| ES2360573T3 (es) | 2011-06-07 |
| ATE498325T1 (de) | 2011-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2173196E (pt) | Uso de probi?ticos e fibras para a diarreia | |
| IN2012DN01638A (pl) | ||
| MX337838B (es) | Secuencias de repetidos palindromicos cortos regularmente intercalados agrupados de bifidobacterias. | |
| MX2009012255A (es) | Probioticos en ambiente pre y/o postquirurgico. | |
| MY156849A (en) | Novel lactobacillus plantarum and composition comprising the same | |
| IL200407A0 (en) | Stable digestive enzyme compositions, methods of producing the same and uses thereof | |
| PL2134833T3 (pl) | Probiotyczny szczep Bifidobacterium | |
| WO2008053444A3 (en) | Treating a respiratory condition with bifidobacterium | |
| UA100551C2 (en) | Synbiotic mixture | |
| WO2009130423A3 (fr) | Nouvelle souche de lactobacillus paracasei subsp. paracasei dotee de proprietes antimicrobiennes et immunomodulatrices | |
| WO2009122042A3 (fr) | Souche de lactobacillus rhamnosus | |
| PH12013502192A1 (en) | Antibodies against human angiopoietin 2 | |
| GB2460781A (en) | Probiotic bifidobacterium strains | |
| MX2011009539A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso. | |
| WO2009156405A8 (en) | Novel immunoadjuvant flagellin-based compounds and use thereof | |
| MX2010007867A (es) | Composiciones de limpieza personal concentradas. | |
| ZA200908063B (en) | Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same | |
| MY158310A (en) | Prevention and treatment of allergic diarrhoea | |
| GB2482817A (en) | Novel use | |
| PH12017502042A1 (en) | Dietary supplement | |
| TN2013000249A1 (en) | Novel bacterium and extracts of said bacterium and the use of same in dermatology | |
| GB0615781D0 (en) | Prebiotic composition | |
| JO2662B1 (en) | Use of 4-methoxy-cyclopropyl-5, 3-N-dichloro-1-oxoperidine-4-yl-5 (methoxy) pyridine-2-carboxamide in the treatment of spinal cord injuries | |
| MX2010007695A (es) | Medios resistentes a abrasion. | |
| AU315844S (en) | Clothing |